Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Page

Showing results (411-420 of 422) with videos related to

Pageof 43
Sort By:
Cell Chemical Biology|June 30, 2021
NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovirSi Min Zhang, Daniel Rehling, Ann-Sofie Jemth, et al.
Chemical Reviews|April 28, 2023
Photobiocatalytic Strategies for Organic SynthesisMegan A Emmanuel, Sophie G Bender, Catherine Bilodeau, et al.
Nature Communications|December 6, 2024
Coupling cellular drug-target engagement to downstream pharmacology with CeTEAMNicholas C K Valerie, Kumar Sanjiv, Oliver Mortusewicz, et al.
Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing|March 26, 2018
Biomarkers as Common Data Elements for Symptom and Self-Management ScienceGayle G Page, Elizabeth J Corwin, Susan G Dorsey, et al.
Molecular Cancer Therapeutics|February 14, 2016
Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer TherapeuticsCarolyn C Arpin, Stephen Mac, Yanlin Jiang, et al.
Nature Communications|January 19, 2018
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cellsBrent D G Page, Nicholas C K Valerie, Roni H G Wright, et al.
Nature Communications|November 3, 2019
Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cellsBrent D G Page, Nicholas C K Valerie, Roni H G Wright, et al.
Leukemia|August 20, 2014
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemiaAnna M Eiring, Brent D G Page, Ira L Kraft, et al.
Leukemia|May 4, 2017
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemiaA M Eiring, B D G Page, I L Kraft, et al.
Nature Medicine|January 10, 2017
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignanciesNikolas Herold, Sean G Rudd, Linda Ljungblad, et al.
Pageof 43

Showing results (411-420 of 422) with videos related to

Sort By:
Pageof 43
Cell Chemical Biology|June 30, 2021
NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovirSi Min Zhang, Daniel Rehling, Ann-Sofie Jemth, et al.
Chemical Reviews|April 28, 2023
Photobiocatalytic Strategies for Organic SynthesisMegan A Emmanuel, Sophie G Bender, Catherine Bilodeau, et al.
Nature Communications|December 6, 2024
Coupling cellular drug-target engagement to downstream pharmacology with CeTEAMNicholas C K Valerie, Kumar Sanjiv, Oliver Mortusewicz, et al.
Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing|March 26, 2018
Biomarkers as Common Data Elements for Symptom and Self-Management ScienceGayle G Page, Elizabeth J Corwin, Susan G Dorsey, et al.
Molecular Cancer Therapeutics|February 14, 2016
Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer TherapeuticsCarolyn C Arpin, Stephen Mac, Yanlin Jiang, et al.
Nature Communications|January 19, 2018
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cellsBrent D G Page, Nicholas C K Valerie, Roni H G Wright, et al.
Nature Communications|November 3, 2019
Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cellsBrent D G Page, Nicholas C K Valerie, Roni H G Wright, et al.
Leukemia|August 20, 2014
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemiaAnna M Eiring, Brent D G Page, Ira L Kraft, et al.
Leukemia|May 4, 2017
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemiaA M Eiring, B D G Page, I L Kraft, et al.
Nature Medicine|January 10, 2017
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignanciesNikolas Herold, Sean G Rudd, Linda Ljungblad, et al.
Pageof 43